cbdMD (NYSEAMERICAN:YCBD) Shares Down 3.5% – Should You Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s stock price traded down 3.5% during mid-day trading on Friday . The stock traded as low as $0.7150 and last traded at $0.7235. 326,417 shares were traded during trading, an increase of 55% from the average session volume of 211,087 shares. The stock had previously closed at $0.75.

cbdMD Trading Down 3.5%

The company has a fifty day simple moving average of $0.79 and a 200-day simple moving average of $0.87.

cbdMD (NYSEAMERICAN:YCBD) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). cbdMD had a negative net margin of 13.29% and a negative return on equity of 33.60%. The company had revenue of $5.64 million for the quarter, compared to the consensus estimate of $5.29 million.

Hedge Funds Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC acquired a new stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned approximately 0.49% of cbdMD as of its most recent SEC filing. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Company Profile

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.